Abstract
The colon is one structural unit with two embryological origins. The cecum and right and midtransverse colons are of midgut origin and as such are supplied by the superior mesenteric artery (SMA). The distal transverse, splenic flexure, and descending and sigmoid colon are of hindgut origin and receive blood from the inferior mesenteric artery (IMA). The entire colon starts as a midline structure that rotates during development and attaches laterally to the right and left posterior peritoneum. The right and left colonic mesenteries are obliterated, fusing to the posterior peritoneum in these regions, leaving these portions of the colon covered by peritoneum on the lateral, anterior, and medial surfaces. The transverse and sigmoid colons, in contrast, are completely covered with peritoneum and are attached by long mesenteries, allowing for great variation in the location of these structures (Fig. 51.1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Garcia-Ruiz, A., et al. Right colonic arterial anatomy. Implications for laparoscopic surgery. Dis Colon Rectum, 1996;39:906–11.
Michels, N.A., et al. Routes of collateral circulation of the gastrointestinal tract as ascertained in a dissection of 500 bodies. Int Surg, 1968,49:8–28.
Michels, N.A., et al. The variant blood supply to the descending colon, rectosigmoid and rectum based on 400 dissections. Its importance in regional resections: a review of medical literature. Dis Colon Rectum, 1965,49:251–78.
Moskowitz, M., H. Zimmerman, and B. Felson. The meandering mesenteric artery of the colon. Am J Roentgenol Radium Ther Nucl Med, 1964;92:1088–99.
Sato, K., and T. Sato. The vascular and neuronal composition of the lateral ligament of the rectum and the rectosacral fascia. Surg Radiol Anat, 1991;13:17–22.
Crapp, A.R., and A.M. Cuthbertson. William Waldeyer and the rectosacral fascia. Surg Gynecol Obstet, 1974;138:252–6.
Greene, F.L., et al., eds. AJCC Cancer Staging Manual. 6th ed. Springer: New York; 2002.
Nivatvongs, S., H.S. Stern, and D.S. Fryd, The length of the anal canal. Dis Colon Rectum, 1981;24:600–1.
Ayoub, S.F. Anatomy of the external anal sphincter in man. Acta Anat (Basel), 1979;105:25–36.
Nielsen, M.B., et al. Endosonography of the anal sphincter: findings in healthy volunteers. AJR Am J Roentgenol, 1991; 157:1199–202.
Shafik, A. A new concept of the anatomy of the anal sphincter mechanism and the physiology of defecation. The external anal sphincter: a triple-loop system. Invest Urol, 1975;12:412–9.
Goligher, J.C., A.G. Leacock, and J.J. Brossy. The surgical anatomy of the anal canal. Br J Surg, 1955;43:51–61.
Parks, A.G. Pathogenesis and treatment of fistula-in-ano. Br Med J, 1961;5224:463–9.
Fenger, C. The anal transitional zone. Acta Pathol Microbiol Immunol Scand Suppl, 1987;289:1–42.
Ayoub, S.F. Arterial supply to the human rectum. Acta Anat (Basel), 1978;100:317–27.
Fisher, D.F., Jr., and W.J. Fry. Collateral mesenteric circulation. Surg Gynecol Obstet, 1987;164:487–92.
Havenga, K., et al. Anatomical basis of autonomic nerve-preserving total mesorectal excision for rectal cancer. Br J Surg, 1996;83:384–8.
Cherry, D.A., and D.A. Rothenberger. Pelvic floor physiology. Surg Clin North Am, 1988;68:1217–30.
Matzel, K.E., R.A. Schmidt, and E.A. Tanagho. Neuroanatomy of the striated muscular anal continence mechanism. Implications for the use of neurostimulation. Dis Colon Rectum, 1990;33:666–73.
Devroede, G.J., and S.F. Phillips. Conservation of sodium, chloride, and water by the human colon. Gastroenterology, 1969;56:101–9.
Giller, J., and S.F. Phillips. Electrolyte absorption and secretion in the human colon. Am J Dig Dis, 1972;17:1003–11.
Garcia, D., et al. Colonic motility: electric and manometric description of mass movement. Dis Colon Rectum, 1991;34:577–84.
Narducci, F., et al. Twenty four hour manometric recording of colonic motor activity in healthy man. Gut, 1987;28:17–25.
Latella, G., and R. Caprilli. Metabolism of large bowel mucosa in health and disease. Int J Colorectal Dis, 1991;6:127–32.
Gaginella, T.S. Absorption and secretion in the colon. Curr Opin Gastroenterol, 1995;11:2–8.
Bokkenheuser, V. The friendly anaerobes. Clin Infect Dis, 1993;16Suppl 4:S427–34.
Henry, M.M., and J.P. Thomson. The anal sphincter. Scand J Gastroenterol Suppl, 1984;93:53–7.
Madoff, R.D., J.G. Williams, and P.F. Caushaj. Fecal incontinence. N Engl J Med, 1992;326:1002–7.
Parks, A.G., N.H. Porter, and J. Melzak. Experimental study of the reflex mechanism controlling the muscle of the pelvic floor. Dis Colon Rectum, 1962;5:407–14.
Thomson, W.H. The nature of haemorrhoids. Br J Surg, 1975;62:542–52.
Gibbons, C.P., et al. Role of anal cushions in maintaining continence. Lancet, 1986;1:886–8.
Loder, P.B., et al. Haemorrhoids: pathology, pathophysiology and aetiology. Br J Surg, 1994;81:946–54.
Miller, R., et al. Sensory discrimination and dynamic activity in the anorectum: evidence using a new ambulatory technique. Br J Surg, 1988;75:1003–7.
Janowitz, H.D. Crohn’s disease-50 years later. N Engl J Med, 1981;304:1600–2.
Crohn, B.B., Ginzburg, L., and G. D., Oppenheimer. Regional ileitis. JAMA, 1932;99:1323–1329.
Nivatvongs, S., and P.H. Gordon. Crohn’s disease In: Principles and Practice of Surgery for the Colon, Rectum, and Anus, P.H. Gordon and S. Nivatvongs, eds. St. Louis: Quality Medical; 1999:907–974.
Russel, M.G., and R.W. Stockbrugger. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol, 1996;31:417–27.
Leong, R.W., J.Y. Lau, and J.J. Sung. The epidemiology and phenotype of Crohn’s disease in the Chinese population. Inflamm Bowel Dis, 2004;10:646–51.
Probert, C.S., et al. Diet of South Asians with inflammatory bowel disease. Arq Gastroenterol, 1996;33:132–5.
Bernstein, C.N., et al. Epidemiology of Crohn’s disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol, 1999;149:916–24.
Odes, H.S., et al. Epidemiology of Crohn’s disease in southern Israel. Am J Gastroenterol, 1994;89:1859–62.
Anseline, P.F. Crohn’s disease in the Hunter Valley region of Australia. Aust N Z J Surg, 1995;65:564–9.
Katschinski, B., et al. Oral contraceptive use and cigarette smoking in Crohn’s disease. Dig Dis Sci, 1993;38:1596–600.
Cottone, M., et al. Smoking habits and recurrence in Crohn’s disease. Gastroenterology, 1994;106:643–8.
Korzenik, J.R. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol, 2005;39(4 suppl 2):S59–65.
Ogura, Y., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature, 2001;411:603–6.
Cario, E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut, 2005;54:1182–93.
Farmer, R.G., W.A. Hawk, and R.B. Turnbull, Jr. Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology, 1975;68(4 pt 1):627–35.
Ritchie, J.K. The results of surgery for large bowel Crohn’s disease. Ann R Coll Surg Engl, 1990;72:155–7.
Greenstein, A.J. The surgery of Crohn’s disease. Surg Clin North Am, 1987;67:573–96.
Platell, C, et al. Anal pathology in patients with Crohn’s disease. Aust N Z J Surg, 1996;66:5–9.
Marmo, R., et al. Capsule endoscopy versus enteroclysis in the detection of small-bowel involvement in Crohn’s disease: a prospective trial. Clin Gastroenterol Hepatol, 2005;3:772–6.
Prabhakar, L.P., et al. Avoiding a stoma: role for segmental or abdominal colectomy in Crohn’s colitis. Dis Colon Rectum, 1997;40:71–8.
Shorter, R.G. Risks of intestinal cancer in Crohn’s disease. Dis Colon Rectum, 1983;26:686–9.
Ekbom, A., et al. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet, 1990;336:357–9.
Gillen, CD., et al. Crohn’s disease and colorectal cancer. Gut, 1994;35:651–5.
Savoca, P.E., G.H. Ballantyne, and C.E. Cahow. Gastrointestinal malignancies in Crohn’s disease. A 20-year experience. Dis Colon Rectum, 1990;33:7–11.
Greenstein, A.J. Malignancy in Crohn’s disease. Perspect Colon Rectal Surg, 1995;8:137–159.
Mekhjian, H.S., et al. National Cooperative Crohn’s Disease Study: factors determining recurrence of Crohn’s disease after surgery. Gastroenterology, 1979,77(4 pt 2):907–13.
Sachar, D.B. Maintenance strategies in Crohn’s disease. Hospital Practice (office ed), 1996;31:99–106.
Stark, M.E., and W.J. Tremaine. Maintenance of symptomatic remission in patients with Crohn’s disease. Mayo Clin Proc, 1993;68:1183–90.
Malchow, H., et al. European Cooperative Crohn’s Disease Study (ECCDS): results of drug treatment. Gastroenterology, 1984;86:249–66.
Summers, R.W., et al. National Cooperative Crohn’s Disease Study: results of drug treatment. Gastroenterology, 1979;77(4 pt 2):847–69.
Ewe, K., et al. Postoperative recurrence of Crohn’s disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion, 1989;42:224–32.
Singleton, J.W., et al. Mesalamine capsules for the treatment of active Crohn’s disease: results of a 16-week trial. Pentasa Crohn’s Disease Study Group. Gastroenterology, 1993;104:1293–301.
Tremaine, W.J., et al. A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn’s colitis and ileocolitis. J Clin Gastroenterol, 1994;19:278–82.
Hanauer, S.B. Inflammatory bowel disease. N Engl J Med, 1996;334:841–8.
Barlow, A.D., G.A. Clarke, and M.J. Kelly. Acute adrenal crisis in a patient treated with rectal steroids. Colorectal Dis, 2004;6:62–4.
Edsbacker, S., and T. Andersson. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn’s disease. Clin Pharmacokinet, 2004;43:803–21.
Rutgeerts, P., et al. A comparison of budesonide with prednisolone for active Crohn’s disease. N Engl J Med, 1994;331:842–5.
Greenberg, G.R., et al. Oral budesonide for active Crohn’s disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med, 1994;331:836–41.
Sachar, D.B. Budesonide for inflammatory bowel disease. It is a magic bullet? N Engl J Med, 1994;331:873–4.
Sandborn, W.J., et al. Natalizumab induction and maintenance therapy for Crohn’s disease. N Engl J Med, 2005;353:1912–25.
Sutherland, L., et al. Double blind, placebo controlled trial of metronidazole in Crohn’s disease. Gut, 1991;32:1071–5.
Brandt, L.J., et al. Metronidazole therapy for perineal Crohn’s disease: a follow-up study. Gastroenterology, 1982;83:383–7.
Lobo, I.M., et al. Oral ciprofloxacin for treatment of severe infections. Int J Clin Pharmacol Res, 1993;13:81–5.
Present, D.H., et al. Treatment of Crohn’s disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med, 1980;302:981–7.
Pearson, D.C., et al. Azathioprine and 6-mercaptopurine in Crohn’s disease. A meta-analysis. Ann Intern Med, 1995;123:132–42.
Katz, S. Update in medical therapy of ulcerative colitis: newer concepts and therapies. J Clin Gastroenterol, 2005;39:557–69.
Feagan, B.G., et al. Methotrexate for the treatment of Crohn’s disease. The North American Crohn’s Study Group Investigators. N Engl J Med, 1995;332:292–7.
Alfadhli, A.A.F., J.W.D. McDonald, and B.G. Feagan. Methotrexate for induction of remission in refractory Crohn’s disease. Cochrane Database of Systematic Reviews, 2004, Issue 4. Art. No.: CD003459. DOI: 10.1002/14651858.CD003459.pub2.
Present, D.H., and S. Lichtiger. Efficacy of cyclosporine in treatment of fistula of Crohn’s disease. Dig Dis Sci, 1994;39:374–80.
Lowry, P.W., et al. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn’s disease perianal fistulae. Inflamm Bowel Dis, 1999;5:239–45.
Present, D.H., et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med, 1999;340:1398–405.
Akobeng A.K., and M. Zachos. Tumor necrosis factor-alpha antibody for induction of remission in Crohn’s disease. Cochrane Database of Systematic Reviews, 2003, Issue 4. Art. No.: CD003574. DOI: 10.1002/14651858.CD003574.pub 2.
Van Assche, G., S. Vermeire, and P. Rutgeerts. Medical treatment of inflammatory bowel diseases. Curr Opin Gastroenterol, 2005;21:443–7.
Ghosh, S., et al. Natalizumab for active Crohn’s disease. N Engl J Med, 2003;348:24–32.
Rutgeerts, P., et al. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut, 1984;25:665–72.
Whelan, G., et al. Recurrence after surgery in Crohn’s disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology, 1985;88:1826–33.
Kim, N.K., et al. Long-term outcome after ileocecal resection for Crohn’s disease. Am Surg, 1997;63:627–33.
Michelassi, F., et al. Primary and recurrent Crohn’s disease. Experience with 1379 patients. Ann Surg, 1991;214:230–8; discussion 238-40.
Andrews, H.A., P. Lewis, and R.N. Allan. Prognosis after surgery for colonic Crohn’s disease. Br J Surg, 1989;76:1184–90.
Griffiths, A.M., et al. Factors influencing postoperative recurrence of Crohn’s disease in childhood. Gut, 1991;32:491–5.
Penner, R.M., K.L. Madsen, and R.N. Fedorak. Postoperative Crohn’s disease. Inflamm Bowel Dis, 2005;11:765–77.
Sayfan, J., et al. Recurrence after strictureplasty or resection for Crohn’s disease. Br J Surg, 1989;76:335–8.
Guillem, J.G., et al. Factors predictive of persistent or recurrent Crohn’s disease in excluded rectal segments. Dis Colon Rectum, 1992;35:768–72.
Chevalier, J.M., et al. Colectomy and ileorectal anastomosis in patients with Crohn’s disease. Br J Surg, 1994;81:1379–81.
Longo, W.E., et al. Outcome of ileorectal anastomosis for Crohn’s colitis. Dis Colon Rectum, 1992;35:1066–71.
Scammell, B.E., et al. Results of proctocolectomy for Crohn’s disease. Br J Surg, 1987;74:671–4.
Fichera, A., et al. Long-term outcome of surgically treated Crohn’s colitis: a prospective study. Dis Colon Rectum, 2005;48:963–9.
Lockhart-Mummery, H.E. Symposium. Crohn’s disease: anal lesions. Dis Colon Rectum, 1975;18:200–2.
Rankin, G.B., et al. National Cooperative Crohn’s Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology, 1979;77(4 Pt 2):914–20.
Williams, J.G., et al. Fistula-in-ano in Crohn’s disease. Results of aggressive surgical treatment. Dis Colon Rectum, 1991;34:3 78–84.
Buchmann, P., et al. Natural history of perianal Crohn’s disease. Ten year follow-up: a plea for conservatism. Am J Surg, 1980;140:642–4.
Sangwan, Y.P., et al. Perianal Crohn’s disease. Results of local surgical treatment. Dis Colon Rectum, 1996;39:529–35.
Sonoda, T., et al. Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum, 2002;45:1622–8.
Mizrahi, N., et al. Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum, 2002;45:1616–21.
Johnston, E., J. Gaw, and D. Armstrong. Efficacy of biodegrade-able “collagen plug“ versus fibrin glue in closure of anorectal fistulas. Dis Colon Rectum, 2005;48:631.
Levein, D.H., E.L., Gross, and W.S., Auriemma. Anal Crohn’s disease. In: Surgery of the Colon, Rectum, and Anus, M.P. Mazier, Levein, D.H., et al., eds. Philadelphia: Saunders; 1995.
Cohen, Z., and R.S. McLeod. Perianal Crohn’s disease. Gastroenterol Clin North Am, 1987;16:175–89.
Buchman, A.L., M.E. Ament, and J. Doty. Development of squamous cell carcinoma in chronic perineal sinus and wounds in Crohn’s disease. Am J Gastroenterol, 1991;86:1829–32.
Nikias, G., et al. Crohn’s disease and colorectal carcinoma: rectal cancer complicating longstanding active perianal disease. Am J Gastroenterol, 1995;90:216–9.
Wolff, B.G., et al. Anorectal Crohn’s disease. A long-term perspective. Dis Colon Rectum, 1985;28:709–11.
Williamson, P.R., et al. Twenty-year review of the surgical management of perianal Crohn’s disease. Dis Colon Rectum, 1995;38:389–92.
Garland, C.F., et al. Incidence rates of ulcerative colitis and Crohn’s disease in 15 areas of the United States. Gastroenterology, 1981;81:1115–24.
Stewenius, J., et al. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol, 1995;30:38–43.
Farmer, R.G., W.M. Michener, and E.A. Mortimer. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol, 1980;9:271–7.
Lashner, B.A., et al. Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology, 1986;91:1396–400.
Sartor, R.B. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol, 1997;92(12 suppl):5S–HS.
Gordon, J.N., A. Di Sabatino, and T.T. Macdonald. The pathophysiologic rationale for biological therapies in inflammatory bowel disease. Curr Opin Gastroenterol, 2005;21:431–7.
Heller, F., et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity, 2002;17:629–38.
Willenbucher, R.F. Inflammatory bowel disease. Semin Gastrointest Dis, 1996;7:94–104.
Greenstein, A.J., et al. A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer, 1981;48:2742–5.
Gyde, S.N., et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut, 1988;29:206–17.
Sugita, A., et al. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut, 1991;32:167–9.
Choi, P.M., and W.H. Kim. Colon cancer surveillance. Gastroenterol Clin North Am, 1995;24:671–87.
Ekbom, A., et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med, 1990;323:1228–33.
Broome, U., G. Lindberg, and R. Lofberg, Primary sclerosing cholangitis in ulcerative colitis-a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology, 1992;102:1877–80.
Devroede, G.J., et al. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med, 1971;285:17–21.
Ransohoff, D.F., R.H. Riddell, and B. Levin. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum, 1985;28:383–8.
Sachar, D.B., and A.J. Greenstein. Cancer in ulcerative colitis: good news and bad news. Ann Intern Med, 1981;95:642–4.
Rubin, C.E., et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology, 1992;103:1611–20.
Melville, D.M., et al. Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol, 1989;20:1008–14.
Connell, W.R., et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut, 1994;35:1419–23.
Choi, P.M., et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology, 1993;105:418–24.
Rozen, P., et al. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology, 1995;108:1361–70.
Giardiello, F.M., and T.M. Bayless. Colorectal cancer and ulcerative colitis. Radiology, 1996;199:28–30.
Lennard-Jones, J.E., et al. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet, 1983;2:149–52.
Broome, U., et al. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum, 1995;38:1301–5.
Knox, T.A., and M.M. Kaplan. Treatment of primary sclerosing cholangitis with oral methotrexate. Am J Gastroenterol, 1991;86:546–52.
Beuers, U., et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology, 1992;16:707–14.
O’Brien, C.B., et al. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology, 1991;14:838–47.
Cangemi, J.R., et al. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology, 1989;96:790–4.
Gumaste, V., D.B. Sachar, and A.J. Greenstein. Benign and malignant colorectal strictures in ulcerative colitis. Gut, 1992;33:938–41.
Sutherland, L.R., G.R. May, and E.A. Shaffer. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med, 1993;118:540–9.
An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group. Ann Intern Med, 1996;124:204–11.
Travis, S.P., et al. Optimum dose of olsalazine for maintaining remission in ulcerative colitis. Gut, 1994;35:1282–6.
Green, J.R., et al. Short report: comparison of two doses of bal-salazide in maintaining ulcerative colitis in remission over 12 months. Aliment Pharmacol Ther, 1992;6:647–52.
Hanauer, S.B. Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis. Am J Gastroenterol, 2003;98:215–6.
Kane, S.V., and D.J. Bjorkman. The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review. Rev Gastroenterol Disord, 2003;3:210–8.
Sandborn, W.J. Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis. Am J Gastroenterol, 2002;97:2939–41.
d’Albasio, G., et al. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. Am J Gastroenterol, 1997;92:1143–7.
Bernstein, C.N., et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol, 2003;98:2784–8.
Velayos, F.S., J.P. Terdiman, and J.M. Walsh. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol, 2005;100:1345–53.
Margolin, M.L., et al. Clinical trials in ulcerative colitis: II. Historical review. Am J Gastroenterol, 1988;83:227–43.
Hanauer, S.B., and G. Stathopoulos. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease. DrugSaf, 1991;6:192–219.
Hanauer, S.B., et al. Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. US Budesonide Enema Study Group. Gastroenterology, 1998;115:525–32.
Lindgren, S., et al. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Scand J Gastroenterol, 2002;37:705–10.
Adler, D.J., and B.I. Korelitz. The therapeutic efficacy of 6-mer-captopurine in refractory ulcerative colitis. Am J Gastroenterol, 1990;85:717–22.
Choi, P.M., and S.R. Targan. Immunomodulator therapy in inflammatory bowel disease. Dig Dis Sci, 1994;39:1885–92.
Gionchetti, P., et al. Standard treatment of ulcerative colitis. Dig Dis, 2003;21:157–67.
Ardizzone, S., et al. Guidelines for the treatment of ulcerative colitis in remission. Eur J Gastroenterol Hepatol, 1997;9:836–41.
George, J., et al. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol, 1996;91:1711–4.
Warman, J.I., et al. Cumulative experience with short-and long-term toxicity to 6-mercaptopurine in the treatment of Crohn’s disease and ulcerative colitis. J Clin Gastroenterol, 2003;37:220–5.
Lichtiger, S., et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med, 1994;330:1841–5.
Message, L., et al. Efficacy of intravenous cyclosporin in moderately severe ulcerative colitis refractory to steroids. Gastroenterol Clin Biol, 2005;29:231–5.
de Saussure, P., et al. Low-dose oral microemulsion cyclosporin for severe, refractory ulcerative colitis. Aliment Pharmacol Ther, 2005;22:203–8.
Plevy, S., et al. A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis. Results of a phase I study. Gastroenterology, 2004;126:A75.
Langholz, E., et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology, 1994;107:3–11.
Kock, N.G. Intra-abdominal “reservoir” in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal “continence” in five ileostomy patients. Arch Surg, 1969;99:223–31.
Litle, V.R., et al. The continent ileostomy: long-term durability and patient satisfaction. J Gastrointest Surg, 1999;3:625–32.
Parks, A.G., and R.J. Nicholls. Proctocolectomy without ileostomy for ulcerative colitis. Br Med J, 1978;2:85–8.
Gunnarsson, U., et al. Proctocolectomy and pelvic pouch—is a diverting stoma dangerous for the patient? Colorectal Dis, 2004;6:23–7.
Ky, A.J., T. Sonoda, and J.W. Milsom. One-stage laparoscopic restorative proctocolectomy: an alternative to the conventional approach? Dis Colon Rectum, 2002;45:207–10;discussion 210-1.
Gilchrist, K.W., B.A. Harms, and J.R. Starling. Abnormal rectal mucosa of the anal transitional zone in ulcerative colitis. Arch Surg, 1995;130:981–3.
Hurst, R.D., and F. Michelassi. Ileal-pouch anal restorative proctocolectomy for ulcerative colitis. Adv Surg, 2004;38:311–36.
Berndtsson, I., T. Oresland, and L. Hulten. Sexuality in patients with ulcerative colitis before and after restorative proctocolectomy: a prospective study. Scand J Gastroenterol, 2004;39:374–9.
Slors, F.J., P.P. van Zuijlen, and G.J. van Dijk. Sexual and bladder dysfunction after total mesorectal excision for benign diseases. Scand J Gastroenterol Suppl, 2000:48–51.
Alexander-Williams, J. The technique of intestinal strictureplasty. Int J Colorectal Dis, 1986;1:54–7.
Dehn, T.C., et al. Ten-year experience of strictureplasty for obstructive Crohn’s disease. Br J Surg, 1989;76:339–41.
Spencer, M.P., et al. Strictureplasty for obstructive Crohn’s disease: the Mayo experience. Mayo Clin Proc, 1994;69:33–6.
Quandalle, P., et al. Long-term follow-up of strictureplasty in Crohn’s disease. Acta Gastroenterol Belg, 1994;57(5–6):314–9.
Baba, S., and K. Nakai, Strictureplasty for Crohn’s disease in Japan. J Gastroenterol, 1995;30Suppl 8:135–8.
Serra, J., Z. Cohen, and R.S. McLeod. Natural history of strictureplasty in Crohn’s disease: 9-year experience. Can J Surg, 1995;38:481–5.
Stebbing, J.F., et al. Recurrence and reoperation after strictureplasty for obstructive Crohn’s disease: long-term results [corrected]. Br J Surg, 1995;82:1471–4.
Gardiner, K.R., M.G. Kettlewell, and N.J. Mortensen. Intestinal haemorrhage after strictureplasty for Crohn’s disease. Int J Colorectal Dis, 1996;11:180–2.
Ozuner, G., et al. How safe is strictureplasty in the management of Crohn’s disease? Am J Surg, 1996;171:57–60;discussion 60-1.
Almy, T.P., and D.A. Howell. Medical progress. Diverticular disease of the colon. N Engl J Med, 1980;302:324–31.
Parks, T.G. Natural history of diverticular disease of the colon. Clin Gastroenterol, 1975;4:53–69.
Rodkey, G.V., and C.E. Welch. Changing patterns in the surgical treatment of diverticular disease. Ann Surg, 1984;200:466–78.
Eide, T.J., and H. Stalsberg. Diverticular disease of the large intestine in Northern Norway. Gut, 1979;20:609–15.
Hughes, L.E. Postmortem survey of diverticular disease of the colon. I. Diverticulosis and diverticulitis. Gut, 1969;10:336–444.
Morson, B.C. Pathology of diverticular disease of the colon. Clin Gastroenterol, 1975;4:37–52.
Painter, N.S. Diverticular disease of the colon. The first of the Western diseases shown to be due to a deficiency of dietary fibre. S Afr Med J, 1982;61:1016–20.
Painter, N.S. The cause of diverticular disease of the colon, its symptoms and its complications. Review and hypothesis. J R Coll Surg Edinb, 1985;30:118–22.
Painter, N.S., and D.P. Burkitt, Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol, 1975;4:3–21.
Meyers, M.A., et al. The angioarchitecture of colonic diverticula. Significance in bleeding diverticulosis. Radiology, 1973;108:249–61.
Slack, W.W. The anatomy, pathology, and some clinical features of divericulitis of the colon. Br J Surg, 1962;50:185–90.
Whiteway, J., and B.C. Morson. Pathology of the ageing—diverticular disease. Clin Gastroenterol, 1985;14:829–46.
Ryan, P. Two kinds of diverticular disease. Ann R Coll Surg Engl, 1991;73:73–9.
Manousos, O.N. Diverticular disease of the colon. Dig Dis, 1989;7:86–103.
Whiteway, J., and B.C. Morson. Elastosis in diverticular disease of the sigmoid colon. Gut, 1985;26:258–66.
Wess, L., et al. Cross linking of collagen is increased in colonic diverticulosis. Gut, 1995;37:91–4.
Ulin, A.W., A.E. Pearce, and S.F. Weinstein. Diverticular disease of the colon: surgical perspectives in the past decade. Dis Colon Rectum, 1981;24:276–81.
Taylor, I., and H.L. Duthie. Bran tablets and diverticular disease. Br Med J, 1976;1:988–90.
Thompson, W.G., and D.G. Patel. Clinical picture of diverticular disease of the colon. Clin Gastroenterol, 1986;15:903–16.
McGuire, H.H., Jr., and B.W. Haynes, Jr. Massive hemorrhage for diverticulosis of the colon: guidelines for therapy based on bleeding patterns observed in 50 cases. Ann Surg, 1972;175:847–55.
Casarella, W.J., et al. “Lower” gastrointestinal tract hemorrhage: new concepts based on arteriography. Am J Roentgenol Radium Ther Nucl Med, 1974;121:357–68.
McGuire, H.H., Jr. Bleeding colonic diverticula. A reappraisal of natural history and management. Ann Surg, 1994;220:653–6.
Bokhari, M., et al. Diverticular hemorrhage in the elderly-is it well tolerated? Dis Colon Rectum, 1996;39:191–5.
Baer, J. Pathogenesis of bleeding colonic diverticulosis: new concepts. CRC Crit Rev Diagn Imaging, 1978;11:1–20.
Rossini, F.P., et al. Emergency colonoscopy. World J Surg, 1989;13:190–2.
Emslie, J.T., et al. Technetium-99m-labeled red blood cell scans in the investigation of gastrointestinal bleeding. Dis Colon Rectum, 1996;39:750–4.
Nicholson, M.L., et al. Localization of lower gastrointestinal bleeding using in vivo technetium-99m-labelled red blood cell scintigraphy. Br J Surg, 1989;76:358–61.
Suzman, M.S., et al. Accurate localization and surgical management of active lower gastrointestinal hemorrhage with technetium-labeled erythrocyte scintigraphy. Ann Surg, 1996;224:29–36.
Hunter, J.M., and M.E. Pezim. Limited value of technetium 99m-labeled red cell scintigraphy in localization of lower gastrointestinal bleeding. Am J Surg, 1990;159:504–6.
Gordon, R.L., et al. Selective arterial embolization for the control of lower gastrointestinal bleeding. Am J Surg, 1997;174:24–8.
Athanasoulis, C.A. Angiography in the management of patients with gastrointestinal bleeding. Adv Surg, 1983;16:1–23.
Gostout, C.J., et al. Acute gastrointestinal bleeding. Experience of a specialized management team. J Clin Gastroenterol, 1992;14:260–7.
Jensen, D.M., and G.A. Machicado. Diagnosis and treatment of severe hematochezia. The role of urgent colonoscopy after purge. Gastroenterology, 1988;95:1569–74.
Eaton, A.C. Emergency surgery for acute colonic haemorrhage—a retrospective study. Br J Surg, 1981;68:109–12.
Drapanas, T., et al. Emergency subtotal colectomy: preferred approach to management of massively bleeding diverticular disease. Ann Surg, 1973;177:519–26.
Gianfrancisco, J.A., and H. Abcarian. Pitfalls in the treatment of massive lower gastrointestinal bleeding with “blind” subtotal colectomy. Dis Colon Rectum, 1982;25:441–5.
Rothenberger, D.A., and O. Wiltz. Surgery for complicated diverticulitis. Surg Clin North Am, 1993;73:975–92.
Schoetz, D.J., Jr. Uncomplicated diverticulitis. Indications for surgery and surgical management. Surg Clin North Am, 1993;73:965–74.
Roberts, P., et al. Practice parameters for sigmoid diverticulitis. The Standards Task Force American Society of Colon and Rectal Surgeons. Dis Colon Rectum, 1995;38:125–32.
Rao, P.M., and J.T. Rhea. Colonic diverticulitis: evaluation of the arrowhead sign and the inflamed diverticulum for CT diagnosis. Radiology, 1998;209:775–9.
Werner, A., et al. Multi-slice spiral CT in routine diagnosis of suspected acute left-sided colonic diverticulitis: a prospective study of 120 patients. Eur Radiol, 2003;13:2596–603.
Ambrosetti, P., C. Becker, and F. Terrier. Colonic diverticulitis: impact of imaging on surgical management—a prospective study of 542 patients. Eur Radiol, 2002;12:1145–9.
Ambrosetti, P., et al. Computed tomography in acute left colonic diverticulitis. Br J Surg, 1997;84:532–4.
Montgomery, R.A., A.C. Venbrux, and G.B. Bulkley. Mesenteric vascular insufficiency. Curr Probl Surg, 1997;34:941–1025.
Freischlag, J., R.S. Bennion, and J.E. Thompson, Jr. Complications of diverticular disease of the colon in young people. Dis Colon Rectum, 1986;29:639–43.
Ambrosetti, P., et al. Acute left colonic diverticulitis in young patients. J Am Coll Surg, 1994;179:156–60.
Ambrosetti, P., et al. Prognostic factors from computed tomography in acute left colonic diverticulitis. Br J Surg, 1992;79:117–9.
Hinchey, E.J., P.G. Schaal, and G.K. Richards. Treatment of perforated diverticular disease of the colon. Adv Surg, 1978;12:85–109.
Detry, R., et al. Acute localized diverticulitis: optimum management requires accurate staging. Int J Colorectal Dis, 1992;7:38–42.
Ambrosetti, P., et al. Incidence, outcome, and proposed management of isolated abscesses complicating acute left-sided colonic diverticulitis. A prospective study of 140 patients. Dis Colon Rectum, 1992;35:1072–6.
Schechter, S., et al. Computerized tomographic scan-guided drainage of intra-abdominal abscesses. Preoperative and postoperative modalities in colon and rectal surgery. Dis Colon Rectum, 1994;37:984–8.
Smirniotis, V., et al. Perforated diverticulitis: a surgical dilemma. Int Surg, 1992;77:44–7.
Kronborg, O. Treatment of perforated sigmoid diverticulitis: a prospective randomized trial. Br J Surg, 1993;80:505–7.
Haas, P.A., and G.P. Haas. A critical evaluation of the Hart-mann’s procedure. Am Surg, 1988;54:380–5.
Ling, L., and T. Aberg. Hartmann procedure. Acta Chir Scand, 1984;150:413–7.
Belmonte, C, et al. The Hartmann procedure. First choice or last resort in diverticular disease? Arch Surg, 1996;131:612–5;discussion 616-7.
Salem, L., and D.R. Flum. Primary anastomosis or Hartmann’s procedure for patients with diverticular peritonitis? A systematic review. Dis Colon Rectum, 2004;47:1953–64.
Tyau, E.S., et al. Acute diverticulitis. A complicated problem in the immunocompromised patient. Arch Surg, 1991;126:855–8;discussion 858-9.
McCune, T.R., et al. Colonic screening prior to renal transplantation and its impact on post-transplant colonic complications. Clin Transplant, 1992;6:91–6.
Soravia, C, et al. Acute colonic complications after kidney transplantation. Acta Chir Belg, 1995;95:157–61.
Guzzo, J., and N. Hyman. Diverticulitis in young patients: is resection after a single attack always warranted? Dis Colon Rectum, 2004;47:1187–90; discussion 1190-1.
Spivak, H., et al. Acute colonic diverticulitis in the young. Dis Colon Rectum, 1997;40:570–4.
Vignati, P.V., J.P. Welch, and J.L. Cohen. Long-term management of diverticulitis in young patients. Dis Colon Rectum, 1995;38:627–9.
Ambrosetti, P., et al. Long-term outcome of mesocolic and pelvic diverticular abscesses of the left colon: a prospective study of 73 cases. Dis Colon Rectum, 2005;48:787–91.
Benn, P.L., B.G. Wolff, and D.M. Ilstrup. Level of anastomosis and recurrent colonic diverticulitis. Am J Surg, 1986;151:269–71.
Schmitt, S.L., and S.D. Wexner. Bacterial, fungal, parasitic, and viral colitis. Surg Clin North Am, 1993;73:1055–62.
Bartlett, J.G., et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. N Engl J Med, 1978;298:531–4.
Kelly, C.P., C. Pothoulakis, and J.T. LaMont. Clostridium difficile colitis. N Engl J Med, 1994;330:257–62.
Keating, J.P., et al. Pseudomembranous colitis associated with ampicillin therapy. Am J Dis Child, 1974;128:369–70.
Tedesco, F.J., R.W. Barton, and D.H. Alpers. Clindamycin-associated colitis. A prospective study. Ann Intern Med, 1974;81:429–33.
Wren, S.M., et al. Preoperative oral antibiotics in colorectal surgery increase the rate of Clostridium difficile colitis. Arch Surg, 2005;140:752–6.
Tedesco, F.J., J.K. Corless, and R.E. Brownstein. Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study. Gastroenterology, 1982;83:1259–60.
Kleinfeld, D.I., R.J. Sharpe, and S.T. Donta. Parenteral therapy for antibiotic-associated pseudomembranous colitis. J Infect Dis, 1988;157:389.
Young, G., and M. McDonald. Antibiotic-associated colitis: why do patients relapse? Gastroenterology, 1986;90:1098–9.
Tvede, M., and J. Rask-Madsen. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet, 1989;1:1156–60.
Longo, W.E., et al. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum, 2004;47:1620–6.
Jobe, B.A., et al. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg, 1995;169:480–3.
Vantrappen, G., et al. Yersinia enteritis and enterocolitis: gastroenterological aspects. Gastroenterology, 1977;72:220–7.
Ravdin, J.I., and R.L. Guerrant. A review of the parasite cellular mechanisms involved in the pathogenesis of amebiasis. Rev Infect Dis, 1982;4:1185–207.
Brinker, A.D., A.C. Mackey, and R. Prizont. Tegaserod and ischemic colitis. N Engl J Med, 2004;351:1361–4;discussion 1361-4.
Charles, J.A., et al. Ischemic colitis associated with naratriptan and oral contraceptive use. Headache, 2005;45:386–9.
DiBaise, J.K. Tegaserod-associated ischemic colitis. Pharmacotherapy, 2005;25:620–5.
Radaelli, F., et al. Ischemic colitis associated with rofecoxib. Dig Liver Dis, 2005;37:372–6.
Medina, C, et al. Outcome of patients with ischemic colitis: review of 53 cases. Dis Colon Rectum, 2004;47:180–4.
Gandhi, S.K., et al. Ischemic colitis. Dis Colon Rectum, 1996;39:88–100.
Marston, A., et al. Ischaemic colitis. Gut, 1966;7:1–15.
Philpotts, L.E., et al. Colitis: use of CT findings in differential diagnosis. Radiology, 1994;190:445–9.
Guttormson, N.L., and M.P. Bubrick. Mortality from ischemic colitis. Dis Colon Rectum, 1989;32:469–72.
Tada, M., F. Misaki, and K. Kawai. Analysis of the clinical features of ischemic colitis. Gastroenterol Jpn, 1983;18:204–9.
Binns, J.C., and P. Isaacson. Age-related changes in the colonic blood supply: their relevance to ischaemic colitis. Gut, 1978;19:384–90.
Baixauli, J., R.P. Kiran, and C.P. Delaney. Investigation and management of ischemic colitis. Cleve Clin J Med, 2003;70:920–1, 925-6, 928-30 passim.
Sierocinski, W. Arteries supplying the left colic flexure in man. Folia Morphol (Warsz), 1975;34:117–24.
Sakai, L., R. Keltner, and D. Kaminski. Spontaneous and shock-associated ischemic colitis. Am J Surg, 1980;140:755–60.
Welch, G.H., et al. Total colonic ischemia. Dis Colon Rectum, 1986;29:410–2.
West, B.R., J.E. Ray, and J.B. Gathright. Comparison of transient ischemic colitis with that requiring surgical treatment. Surg Gynecol Obstet, 1980;151:366–8.
Longo, W.E., G.H. Ballantyne, and R.J. Gusberg. Ischemic colitis: patterns and prognosis. Dis Colon Rectum, 1992;35:726–30.
Gama, A.H., et al. Volvulus of the sigmoid colon in Brazil: a report of 230 cases. Dis Colon Rectum, 1976;19:314–20.
Ballantyne, G.H. Review of sigmoid volvulus. Clinical patterns and pathogenesis. Dis Colon Rectum, 1982;25:823–30.
Abel, M.E., and T.R. Russell. Ischemic colitis. Comparison of surgical and nonoperative management. Dis Colon Rectum, 1983;26:113–5.
Parish, K.L., W.C. Chapman, and L.F. Williams, Jr. Ischemic colitis. An ever-changing spectrum? Am Surg, 1991;57:118–21.
Gibney, E.J. Volvulus of the sigmoid colon. Surg Gynecol Obstet, 1991;173:243–55.
String, S.T., and J.J. DeCosse. Sigmoid volvulus. An examination of the mortality. Am J Surg, 1971;121:293–7.
Shepherd, J.J. The epidemiology and clinical presentation of sigmoid volvulus. Br J Surg, 1969;56:353–9.
Mishra, S.B., and K.P. Sahoo. Primary resection and anastomosis for volvulus of sigmoid colon. J Indian Med Assoc, 1986;84:265–8.
Catalano, O. Computed tomographic appearance of sigmoid volvulus. Abdom Imaging, 1996;21:314–7.
Biery, D.L., and S.M. Hoffman. Colonoscopic reduction of sigmoid volvulus. J Am Osteopath Assoc, 1978;77:543–5.
Drapanas, T., and J.D. Stewart. Acute sigmoid volvulus. Concepts in surgical treatment. Am J Surg, 1961;101:70–7.
Orchard, J.L., R. Mehta, and A.H. Khan. The use of colonoscopy in the treatment of colonic volvulus: three cases and review of the literature. Am J Gastroenterol, 1984;79:864–7.
Wertkin, M.G., and A.H. Aufses, Jr. Management of volvulus of the colon. Dis Colon Rectum, 1978;21:40–5.
Brothers, T.E., W.E. Strodel, and F.E. Eckhauser. Endoscopy in colonic volvulus. Ann Surg, 1987;206:1–4.
Mangiante, E.C., et al. Sigmoid volvulus. A four-decade experience. Am Surg, 1989;55:41–4.
Ritvo, M., G.E. Farrell, Jr., and LA. Shauffer. The association of volvulus of the cecum and ascending colon with other obstructive colonic lesions. Am J Roentgenol Radium Ther Nucl Med, 1957;78:587–98.
Rabinovici, R., et al. Cecal volvulus. Dis Colon Rectum, 1990;33:765–9.
Todd, G.J., and K.A. Forde. Volvulus of the cecum: choice of operation. Am J Surg, 1979;138:632–4.
Burke, J.B., and G.H. Ballantyne. Cecal volvulus. Low mortality at a city hospital. Dis Colon Rectum, 1984;27:737–40.
Haskin, P.H., et al. Volvulus of the cecum and right colon. JAMA, 1981;245:2433–5.
Anderson, J.R., and G.H. Welch. Acute volvulus of the right colon: an analysis of 69 patients. World J Surg, 1986;10:336–42.
Tejler, G., and H. Jiborn. Volvulus of the cecum. Report of 26 cases and review of the literature. Dis Colon Rectum, 1988;31:445–9.
Fishman, E.K., et al. Transverse colon volvulus: diagnosis and treatment. South Med J, 1983;76:185–9.
Gumbs, M.A., et al. Volvulus of the transverse colon. Reports of cases and review of the literature. Dis Colon Rectum, 1983;26:825–8.
Kerry, R.L., and H.K. Ransom. Volvulus of the colon. Arch Surg, 1969;99:215–22.
Zinkin, L.D., L.D. Katz, and J.D. Rosin. Volvulus of the transverse colon: report of case and review of the literature. Dis Colon Rectum, 1979;22:492–6.
Moore-Gillon, V. Constipation: what does the patient mean? J R Soc Med, 1984;77:108–10.
Burkitt, D.P., A.R. Walker, and N.S. Painter. Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet, 1972;2:1408–12.
Burkitt, D.P., A.R. Walker, and N.S. Painter. Dietary fiber and disease. JAMA, 1974;229:1068–74.
Painter, N.S., and D.P. Burkitt. Diverticular disease of the colon: a deficiency disease of Western civilization. Br Med J, 1971;2:450–4.
Walker, A.R., B.F. Walker, and B.D. Richardson. Bowel transit times in Bantu populations. Br Med J, 1970;3:48–9.
Jemal, A., et al. Cancer statistics, 2005. CA Cancer J Clin, 2005;55:10–30.
Cucino, C, A.M. Buchner, and A. Sonnenberg. Continued right-ward shift of colorectal cancer. Dis Colon Rectum, 2002;45:1035–40.
Caygill, C.P., A. Charlett, and M.J. Hill. Fat, fish, fish oil and cancer. Br J Cancer, 1996;74:159–64.
Rose, D.P., A.P. Boyar, and E.L. Wynder. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer, 1986;58:2363–71.
Chao, A., et al. Meat consumption and risk of colorectal cancer. JAMA, 2005;293:172–82.
Kim, Y.I. AGA technical review: impact of dietary fiber on colon cancer occurrence. Gastroenterology, 2000;118:1235–57.
Giovannucci, E. Obesity, gender, and colon cancer. Gut, 2002;51:147.
Terry, P.D., A.B. Miller, and T.E. Rohan. Obesity and colorectal cancer risk in women. Gut, 2002;51:191–4.
Potter, J.D. Colorectal cancer: molecules and populations. J Natl Cancer Inst, 1999;91:916–32.
Burt, R.W. Colon cancer screening. Gastroenterology, 2000;119:837–53.
Fuchs, C.S., et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med, 1994;331:1669–74.
Lennard-Jones, J.E., et al. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut, 1990;31:800–6.
Fearon, E.R., and B. Vogelstein. A genetic model for colorectal tumorigenesis. Cell, 1990;61:759–67.
Loeb, L.A. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res, 1994;54:5059–63.
Shibata, D., et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med, 1996;335:1727–32.
Vogelstein, B., and K.W. Kinzler. p53 function and dysfunction. Cell, 1992;70:523–6.
Greenblatt, M.S., et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res, 1994;54:4855–78.
McLeod, H.L., and G.I. Murray. Tumour markers of prognosis in colorectal cancer. Br J Cancer, 1999;79:191–203.
Soong, R., et al. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation. Eur J Cancer, 2000;36:2053–60.
Minamoto, T., M. Mai, and Z. Ronai. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers—a review. Cancer Detect Prev, 2000;24:1–12.
Ahnen, D.J., et al. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res, 1998;58:1149–58.
Merg, A., et al. Hereditary colorectal cancer-part II. Curr Probl Surg, 2005;42:267–333.
Salonga, D., et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res, 2000;6:1322–7.
Diasio, R.B., T.L. Beavers, and J.T. Carpenter. Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity. J Clin Invest, 1988;81:47–51.
Zeng, Z., A.M. Cohen, and C. Urmacher. Usefulness of carcino-embryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum, 1993;36:1063–8.
Bruinvels, D.J., et al. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg, 1994;219:174–82.
Renehan, A.G., et al. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ, 2002;324:813.
Rosen, M., et al. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum, 1998;41:1116–26.
Pignone, M., et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med, 2002;137:96–104.
Mandel, J.S., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med, 1993;328:1365–71.
Hardcastle, J.D., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 1996;348:1472–7.
Kronborg, O., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 1996;348:1467–71.
Towler, B.P., et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev, 2000:CD001216.
Selby, J.V., et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med, 1992;326:653–7.
Atkin, W.S., et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen, 2001;8:137–44.
Prorok, P.C., et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials, 2000;21(6 suppl):273S–309S.
Muller, A.D., and A. Sonnenberg. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med, 1995;155:1741–8.
Newcomb, P.A., et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst, 1992;84:1572–5.
Thomas, R.D., J.J. Fairhurst, and R.A. Frost. Wessex regional radiology audit: barium enema in colo-rectal carcinoma. Clin Radiol, 1995;50:647–50.
Tawn, D.J., et al. National audit of the sensitivity of double-contrast barium enema for colorectal carcinoma, using control charts for the Royal College of Radiologists Clinical Radiology Audit Sub-Committee. Clin Radiol, 2005;60:558–64.
Kewenter, J., et al. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test. Endoscopy, 1995;27:159–63.
Blakeborough, A., M.B. Sheridan, and A.H. Chapman. Complications of barium enema examinations: a survey of UK consultant radiologists 1992 to 1994. Clin Radiol, 1997;52:142–8.
Waye, J.D., B.S. Lewis, and S. Yessayan. Colonoscopy: a prospective report of complications. J Clin Gastroenterol, 1992;15:347–51.
Nelson, D.B., et al. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc, 2002;55:307–14.
Winawer, S.J., and A.G. Zauber. Colonoscopic polypectomy and the incidence of colorectal cancer. Gut, 2001;48:753–4.
Winawer, S.J., and A.G. Zauber. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am, 2002;12:1–9, v.
Rex, D.K., et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology, 1997;112:24–8.
Winawer, S.J., et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med, 2000;342:1766–72.
Zarchy, T.M., and D. Ershoff. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? Gastroenterology, 1994;106:1501–4.
Pickhardt, P.J., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med, 2003;349:2191–200.
Cotton, P.B., et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA, 2004;291:1713–9.
Imperiale, T.F., et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med, 2004;351:2704–14.
Runkel, N.S., et al. Outcome after emergency surgery for cancer of the large intestine. Br J Surg, 1991;78:183–8.
Mandava, N., et al. Perforated colorectal carcinomas. Am J Surg, 1996;172:236–8.
Beart, R.W., et al. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg, 1995;181:225–36.
Gold, J.S., S. Bayar, and R.R. Salem. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg, 2004;139:760–5.
Isler, J.T., et al. The role of preoperative colonoscopy in colorectal cancer. Dis Colon Rectum, 1987;30:435–9.
Slater, G., P. Fleshner, and A.H. Aufses, Jr. Colorectal cancer location and synchronous adenomas. Am J Gastroenterol, 1988;83:832–6.
Compton, C., et al. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer, 2000;88:1739–57.
Mauchley, D.C., et al. Clinical utility and cost-effectiveness of routine preoperative computed tomography scanning in patients with colon cancer. Am J Surg, 2005;189:512–7; discussion 517.
Kerner, B.A., et al. Is preoperative computerized tomography useful in assessing patients with colorectal carcinoma? Dis Colon Rectum, 1993;36:1050–3.
Garcia-Aguilar, J., et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum, 2002;45:10–5.
Winawer, S.J., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med, 1993;329:1977–81.
Stryker, S.J., et al. Natural history of untreated colonic polyps. Gastroenterology, 1987;93:1009–13.
Winawer, S.J. Natural history of colorectal cancer. Am J Med, 1999;106(1 A):3S–6S; discussion 50S–51S.
Atkin, W.S., B.C. Morson, and J. Cuzick. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med, 1992;326:658–62.
O’Brien, M.J., et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology, 1990;98:371–9.
Macrae, F.A., et al. Towards safer colonoscopy: a report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut, 1983;24:376–83.
Franklin, M.E., et al. Laparoscopic-assisted colonoscopic polypectomy: the Texas Endosurgery Institute experience. Dis Col Rectum 2000;43:1246–9.
Kikuchi, R., et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum, 1995;38:1286–95.
Nascimbeni, R., et al. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum, 2002;45:200–6.
Nivatvongs, S. Surgical management of malignant colorectal polyps. Surg Clin North Am, 2002;82:959–66.
Nivatvongs, S., et al. Villous adenomas of the rectum: the accuracy of clinical assessment. Surgery, 1980;87:549–51.
Havelaar, I.J., et al. Rate of growth of intraabdominal metastases from colorectal cancer. Cancer, 1984;54:163–71.
Slim, K., et al. Meta-analysis of randomized clinical trials of colorectal surgery with or without mechanical bowel preparation. Br J Surg, 2004;91:1125–30.
Wille-Jorgensen, P., et al. Pre-operative mechanical bowel cleansing or not? An updated meta-analysis. Colorectal Dis, 2005;7:304–10.
Bucher, P., et al. Randomized clinical trial of mechanical bowel preparation versus no preparation before elective left-sided colorectal surgery. Br J Surg, 2005;92:409–14.
Nelson, H., et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst, 2001;93:583–96.
Le Voyer, T.E., et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol, 2003;21:2912–9.
Goldstein, N.S. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol, 2002;26:179–89.
Wong, J.H., et al. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol, 1999;17:2896–900.
Lopez, M.J., and W.W. Monafo. Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery, 1993;113:365–72.
Keating, J., et al. The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry? N Z Med J, 2003;116:U437.
Chu, D.Z., et al. The significance of synchronous carcinoma and polyps in the colon and rectum. Cancer, 1986;57:445–50.
Passman, M.A., R.F. Pommier, and J.T. Vetto. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum, 1996;39:329–34.
Feig, B.W., et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg, 2001;182:707–12.
Bertagnolli, M., et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg, 2004;240:624–8; discussion 628–30.
Saha, S., et al. Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trial. Dis Colon Rectum, 2004;47:1767–72.
Lacy, A.M., et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial [see comment]. Lancet, 2002;359:2224–9.
A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med, 2004;350:2050–9.
Guillou, P.J., et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet, 2005;365:1718–26.
Hazebroek, E.J., and G. Color Study. COLOR: a randomized clinical trial comparing laparoscopic and open resection for colon cancer. Surg Endosc, 2002;16:949–53.
Leung, K.L., et al. Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet, 2004;363:1187–92.
Kapiteijn, E., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 2001;345:638–46.
Wilson, S.M., and O.H. Beahrs. The curative treatment of carcinoma of the sigmoid, rectosigmoid, and rectum. Ann Surg, 1976;183:556–65.
Killingback, M. Local excision of carcinoma of the rectum: indications. World J Surg, 1992;16:437–46.
Graham, R.A., L. Garnsey, and J.M. Jessup. Local excision of rectal carcinoma. Am J Surg, 1990;160:306–12.
Steele, G.D., Jr., et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol, 1999;6:433–41.
Russell, A.H., et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys, 2000;46:313–22.
Varma, M.G., et al. Local excision of rectal carcinoma. Arch Surg, 1999;134:863–7; discussion 867–8.
Habr-Gama, A., et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg, 2004;240:711–7; discussion 717–8.
Bonnen, M., et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys, 2004;60:1098–105.
Papillon, J., and P. Berard. Endocavitary irradiation in the conservative treatment of adenocarcinoma of the low rectum. World J Surg, 1992;16:451–7.
Buess, G., et al. Technique of transanal endoscopic microsurgery. Surg Endosc, 1988;2:71–5.
Middleton, P.F., L.M. Sutherland, and G.J. Maddern. Transanal endoscopic microsurgery: a systematic review. Dis Colon Rectum, 2005;48:270–84.
Smith, L.E., et al. Transanal endoscopic microsurgery. Initial registry results. Dis Colon Rectum, 1996;39(10 suppl):S79–S84.
McGregor, J.R., and P.J. O’Dwyer. The surgical management of obstruction and perforation of the left colon. Surg Gynecol Obstet, 1993;177:203–8.
Wolmark, N., et al. The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials. Ann Surg, 1983;198:743–52.
Deans, G.T., Z.H. Krukowski, and S.T. Irwin. Malignant obstruction of the left colon. Br J Surg, 1994;81:1270–6.
Stephenson, B.M., et al. Malignant left-sided large bowel obstruction managed by subtotal/total colectomy. Br J Surg, 1990;77:1098–102.
Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. The SCOTIA Study Group. Subtotal colectomy versus on-table irrigation and anastomosis. Br J Surg, 1995;82:1622–7.
Willett, C.G., et al. Does postoperative irradiation play a role in the adjuvant therapy of stage T4 colon cancer? Cancer J Sci Am, 1999;5:242–7.
Laurie, J.A., et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol, 1989;7:1447–56.
Moertel, C.G., et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med, 1990;322:352–8.
Rustum, Y.M., S. Cao, and Z. Zhang. Rationale for treatment design: biochemical modulation of 5-fluorouracil by leucovorin. Cancer J Sci Am, 1998;4:12–8.
Wolmark, N., L. Colangelo, and S. Wieand. National Surgical Adjuvant Breast and Bowel Project trials in colon cancer. Semin Oncol, 2001;28(1 suppl 1):9–13.
Scheithauer, W., et al. Oral capecitabine as an alternative to IV 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol, 2003;14:1735–43.
Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med, 1997;336:980–7.
Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med, 1985;312:1465–72.
Krook, J.E., et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med, 1991;324:709–15.
O’Connell, M.J., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med, 1994;331:502–7.
Sauer, R., et al. Preoperative versus postoperative chemoradio-therapy for rectal cancer. N Engl J Med, 2004;351:1731–40.
Galandiuk, S., et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet, 1992;174:27–32.
Young-Fadok, T.M., et al. Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial. Dis Colon Rectum, 1998;41:277–83; discussion 283–5.
Scheele, J., and A. Altendorf-Hofmann. Resection of colorectal liver metastases. Langenbecks Arch Surg, 1999;384:313–27.
Scheithauer, W., et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ, 1993;306:752–5.
Van Cutsem, E., et al. Oral capecitabine versus intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer, 2004;90:1190–7.
Douillard, J.Y., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet, 2000;355:1041–7.
Grothey, A., and R.M. Goldberg. A review of oxaliplatin and its clinical use in colorectal cancer. Expert Opin Pharmacother, 2004;5:2159–70.
Hoff, P.M., et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol, 2001;19:2282–92.
Douillard, J.Y., et al. Multicenter phase HI study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol, 2002;20:3605–16.
Hurwitz, H., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med, 2004;350:2335–42.
Cunningham, D., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med, 2004;351:337–45.
Scheele, J., et al. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery, 1991;110:13–29.
Abdalla, E.K., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg, 2004;239:818–25; discussion 825–7.
Fong, Y., et al. Liver resection for colorectal metastases. J Clin Oncol, 1997;15:938–46.
Nadig, D.E., et al. Major hepatic resection. Indications and results in a national hospital system from 1988 to 1992. Arch Surg, 1997;132:115–9.
Sugawara, G., et al. Repeat hepatectomy for recurrent colorectal metastases. Surg Today, 2005;35:282–9.
Tuttle, T.M., S.A. Curley, and M.S. Roh. Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol, 1997;4:125–30.
Petrowsky, H., et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg, 2002;235:863–71.
Wanebo, H.J., et al. Patient selection for hepatic resection of colorectal metastases. Arch Surg, 1996;131:322–9.
Madoff, D.C., E.K. Abdalla, and J.N. Vauthey. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol, 2005;16:779–90.
Lorenz, M., and H.H. Muller. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol, 2000;18:243–54.
Kemeny, M.M., et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy—an intergroup study. J Clin Oncol, 2002;20:1499–505.
Kemeny, N.E., and M. Gonen. Hepatic arterial infusion after liver resection. N Engl J Med, 2005;352:734–5.
Saito, Y., et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardio-vasc Surg, 2002;124:1007–13.
Pfannschmidt, J., et al. Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: experiences in 167 patients. J Thorac Cardiovasc Surg, 2003;126:732–9.
Ike, H., et al. Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum, 2002;45:468–73; discussion 473–5.
Verwaal, V.J., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol, 2003;21:3737–43.
Russell, A.H., et al. Adenocarcinoma of the proximal colon. Sites of initial dissemination and patterns of recurrence following surgery alone. Cancer, 1984;53:360–7.
Gunderson, L.L., H. Sosin, and S. Levitt. Extrapelvic colon-areas of failure in a reoperation series: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys, 1985;11:731–41.
Obrand, D.I., and P.H. Gordon. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum, 1997;40:15–24.
Bowne, W.B., et al. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum, 2005;48:897–909.
Hahnloser, D., et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg, 2003;237:502–8.
Mohiuddin, M., G. Marks, and J. Marks. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer, 2002;95:1144–50.
Juffermans, J.H., et al. Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect. Cancer, 2003;98:1759–66.
van der Zee, J., et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet, 2000;355:1119–25.
Church, J., A. Lowry, and C. Simmang. Practice parameters for the identification and testing of patients at risk for dominantly inherited colorectal cancer-supporting documentation. Dis Colon Rectum, 2001;44:1404–12.
Gingold, B.S., D. fagelman, and R.B. Turnbull. Surgical management of familial polyposis and Gardner’s syndrome. Am J Surg, 1979;137:54–6.
Sampson, J.R., et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet, 2003;362:39–41.
Sieber, O.M., et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med, 2003;348:791–9.
Al-Tassan, N., et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet, 2002;30:227–32.
Wang, L., et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology, 2004;127:9–16.
Giardiello, F.M., et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med, 1987;316:1511–4.
Spigelman, A.D., V. Murday, and R.K. Phillips. Cancer and the Peutz-Jeghers syndrome. Gut, 1989;30:1588–90.
Wirtzfeld, D.A., N.J. Petrelli, and M.A. Rodriguez-Bigas. Hamar-tomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol, 2001;8:319–27.
Coburn, M.C., et al. Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol, 1995;2:386–91.
Jass, J.R., et al. Juvenile polyposis-a precancerous condition. Histopathology, 1988;13:619–30.
Itoh, H., et al. Risk of cancer death in first-degree relatives of patients with hereditary non-polyposis cancer syndrome (Lynch type II): a study of 130 kindreds in the United Kingdom. Br J Surg, 1990;77:1367–70.
Lynch, H.T., and A. de la Chapelle. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet, 1999;36:801–18.
Aarnio, M., et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer, 1995;64:430–3.
Plaschke, J., et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germ-line mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol, 2004;22:4486–94.
Jass, J.R., et al. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res, 1994; 14(4B): 1631–4.
Winawer, S.J., et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med, 1996;334:82–7.
Church, J., and C. Simmang. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary non-polyposis colorectal cancer). Dis Colon Rectum, 2003;46:1001–12.
Winawer, S.J., et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst, 1993;85:1311–8.
Kewenter, J., et al. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol, 1994;29:468–73.
Jessup, J.M., et al. The National Cancer Data Base. Report on colon cancer. Cancer, 1996;78:918–26.
Frazee, R.C., et al. Transanal excision of rectal carcinoma. Am Surg, 1995;61:714–7.
Bleday, R., et al. Prospective evaluation of local excision for small rectal cancers. Dis Colon Rectum, 1997;40:388–92.
Ishizaki, Y., et al. Evaluation of local excision for sessile-type lower rectal tumors. Hepatogastroenterology, 1999;46:2329–32.
Chakravarti, A., et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg, 1999;230:49–54.
Mellgren, A., et al. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum, 2000;43:1064–71; discussion 1071–4.
Endreseth, B.H., et al. Transanal excision versus major surgery for Tl rectal cancer. Dis Colon Rectum, 2005;48:1380–8.
Garcia-Aguilar, J., et al. Open vs. closed sphincterotomy for chronic anal fissure: long-term results. Dis Colon Rectum, 1997;40:1439–42.
Bailey, H.R., et al. Local excision of carcinoma of the rectum for cure. Surgery, 1992;111:555–61.
Wagman, R., et al. Conservative management of rectal cancer with local excision and postoperative adjuvant therapy. Int J Radiat Oncol Biol Phys, 1999;44:841–6.
Le Voyer, T.E., et al. Local excision and chemoradiation for low rectal Tl and T2 cancers is an effective treatment. Am Surg, 1999;65:625–30; discussion 630–1.
The evaluation of low dose pre-operative x-ray therapy in the management of operable rectal cancer; results of a randomly controlled trial. Br J Surg, 1984;71:21–5.
Higgins, G.A., et al. Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial H. Cancer, 1986;58:352–9.
Gerard, A., et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg, 1988;208:606–14.
Reis Neto, J.A., F.A. Quilici, and J.A. Reis, Jr. A comparison of nonoperative versus preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial. Dis Colon Rectum, 1989; 32:702–10.
Dahl, O., et al. Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway. Cancer, 1990;66:2286–94.
Goldberg, P.A., et al. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer, 1994;30A:1602–6.
Marsh, P.J., R.D. James, and P.F. Schofield. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial. Dis Colon Rectum, 1994; 37:1205–14.
Cedermark, B., et al. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer, 1995;75:2269–75.
Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group. Ann Surg Oncol, 1996;3:423–30.
Balslev, I., et al. Postoperative radiotherapy in Dukes’ B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer, 1986;58:22–8.
Fisher, B., et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst, 1988;80:21–9.
Treurniet-Donker, A.D., et al. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer, 1991;67: 2042–8.
Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet, 1996;348:1605–10.
Boulis-Wassif, S., et al. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer, 1984;53:1811–8.
Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group. J Clin Oncol, 1992;10:549–57.
Wolmark, N., et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst, 2000;92:388–96.
Vasilevsky, C.A., and P.H. Gordon. The incidence of recurrent abscesses or fistula-in-ano following anorectal suppuration. Dis Colon Rectum, 1984;27:126–30.
Sudol-Szopinska, I., et al. Reliability of endosonography in evaluation of anal fistulae and abscesses. Acta Radiol, 2002;43:599–602.
Cheong, D.M., et al. Anal endosonography for recurrent anal fistulas: image enhancement with hydrogen peroxide. Dis Colon Rectum, 1993;36:1158–60.
Buchanan, G.N., et al. Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in ano: comparison with outcome-based reference standard. Radiology, 2004;233:674–81.
Hussain, S.M., et al. Fistula in ano: endoanal sonography versus endoanal MR imaging in classification. Radiology, 1996;200:475–81.
Whiteford, M.H., et al. Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised). Dis Colon Rectum, 2005;48:1337–42.
Inceoglu, R., and R. Gencosmanoglu. Fistulotomy and drainage of deep postanal space abscess in the treatment of posterior horseshoe fistula. BMC Surg, 2003;3:10.
Cirocco, W.C., and J.C. Reilly. Challenging the predictive accuracy of Goodsairs rule for anal fistulas. Dis Colon Rectum, 1992;35:537–42.
Marks, C.G., and J.K. Ritchie. Anal fistulas at St Mark’s Hospital. Br J Surg, 1977;64:84–91.
Hananel, N., and P.H. Gordon. Re-examination of clinical manifestations and response to therapy of fissure-in-ano. Dis Colon Rectum, 1997;40:229–33.
Petros, J.G., E.B. Rimm, and R.J. Robillard. Clinical presentation of chronic anal fissures. Am Surg, 1993;59:666–8.
Farouk, R., et al. Sustained internal sphincter hypertonia in patients with chronic anal fissure. Dis Colon Rectum, 1994; 37:424–9.
Keck, J.O., et al. Computer-generated profiles of the anal canal in patients with anal fissure. Dis Colon Rectum, 1995;38:72–9.
Schouten, W.R., et al. Ischaemic nature of anal fissure. Br J Surg, 1996;83:63–5.
Xynos, E., et al. Anal manometry in patients with fissure-in-ano before and after internal sphincterotomy. Int J Colorectal Dis, 1993;8:125–8.
Schouten, W.R., and J.D. Blankensteijn. Ultra slow wave pressure variations in the anal canal before and after lateral internal sphincterotomy. Int J Colorectal Dis, 1992,7:115–8.
Jost, W.H. One hundred cases of anal fissure treated with botulin toxin: early and long-term results. Dis Colon Rectum, 1997;40:1029–32.
Brisinda, G., et al. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med, 1999;341:65–9.
Maria, G., et al. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med, 1998;338:217–20.
Nelson, R. A systematic review of medical therapy for anal fissure. Dis Colon Rectum, 2004;47:422–31.
Lund, J.N., and J.H. Scholefield. Aetiology and treatment of anal fissure. Br J Surg, 1996;83:1335–44.
Lund, J.N., and J.H. Scholefield. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet, 1997;349:11–4.
Lund, J.N., and J.H. Scholefield. Glyceryl trinitrate is an effective treatment for anal fissure. Dis Colon Rectum, 1997;40:468–70.
Oettle, G.J. Glyceryl trinitrate versus sphincterotomy for treatment of chronic fissure-in-ano: a randomized, controlled trial. Dis Colon Rectum, 1997;40:1318–20.
Hyman, N.H., and P.A. Cataldo. Nitroglycerin ointment for anal fissures: effective treatment or just a headache? Dis Colon Rectum, 1999;42:383–5.
Nelson, R. Operative procedures for fissure in ano. Cochrane Database Syst Rev, 2005:CD002199.
Graham-Stewart, C.W. What causes hemorrhoids?A new theory of etiology. Dis Colon Rectum, 1963;127:333–44.
Bernstein, W.C. What are hemorrhoids and what is their relationship to the portal venous system? Dis Colon Rectum, 1983;26:829–34.
Haas, P.A., T.A. Fox, Jr., and G.P. Haas. The pathogenesis of hemorrhoids. Dis Colon Rectum, 1984;27:442–50.
Johanson, J.F., and J. Lafferty. Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol, 1996;91:33–6.
Hosking, S.W., et al. Anorectal varices, haemorrhoids, and portal hypertension. Lancet, 1989;1:349–52.
Wang, T.F., et al. Relationship of portal pressure, anorectal varices and hemorrhoids in cirrhotic patients. J Hepatol, 1992;15(1–2):170–3.
Hiltunen, K.M., and M. Matikainen. Anal manometric findings in symptomatic hemorrhoids. Dis Colon Rectum, 1985;28:807–9.
Sun, W.M., et al. Haemorrhoids are associated not with hypertrophy of the internal anal sphincter, but with hypertension of the anal cushions. Br J Surg, 1992;79:592–4.
Lin, J.K. Anal manometric studies in hemorrhoids and anal fissures. Dis Colon Rectum, 1989;32:839–42.
MacRae, H.M., and R.S. McLeod. Comparison of hemorrhoidal treatment modalities. A meta-analysis. Dis Colon Rectum, 1995;38:687–94.
Cataldo, P., et al. Practice parameters for the management of hemorrhoids (revised). Dis Colon Rectum, 2005;48:189–94.
Buchmann, P., and U. Seefeld. Rubber band ligation for piles can be disastrous in HIV-positive patients. Int J Colorectal Dis, 1989;4:57–8.
Shemesh, E.I., et al. Severe complication of rubber band ligation of internal hemorrhoids. Dis Colon Rectum, 1987;30:199–200.
Quevedo-Bonilla, G., et al. Septic complications of hemorrhoidal banding. Arch Surg, 1988;123:650–1.
O’Donovan, S., et al. Intraoperative use of Toradol facilitates outpatient hemorrhoidectomy. Dis Colon Rectum, 1994;37:793–9.
Hoff, S.D., et al. Ambulatory surgical hemorrhoidectomy-a solution to postoperative urinary retention? Dis Colon Rectum, 1994;37:1242–4.
Nivatvongs, S. Hemorrhoids. In: Principles and Practice of Surgery for the Colon, Rectum, and Anus, S. Nivatvongs and P.H. Gordon, eds. St. Louis: Quality Medical; 1999:193–216.
Basdanis, G., et al. Randomized clinical trial of stapled hemorrhoidectomy versus open with Ligasure for prolapsed piles. Surg Endosc, 2005;19:235–9.
Bikhchandani, J., et al. Randomized controlled trial to compare the early and mid-term results of stapled versus open hemorrhoidectomy. Am J Surg, 2005;189:56–60.
Cheetham, M.J., et al. A randomized, controlled trial of diathermy hemorrhoidectomy versus stapled hemorrhoidectomy in an intended day-care setting with longer-term follow-up. Dis Colon Rectum, 2003;46:491–7.
Chung, C.C., et al. Stapled hemorrhoidopexy versus Harmonic Scalpel hemorrhoidectomy: a randomized trial. Dis Colon Rectum, 2005;48:1213–9.
Gravie, J.F., et al. Stapled hemorrhoidopexy versus Milligan-Morgan hemorrhoidectomy: a prospective, randomized, multi-center trial with 2-year postoperative follow up. Ann Surg, 2005;242:29–35.
Senagore, A.J., et al. A prospective, randomized, controlled mul-ticenter trial comparing stapled hemorrhoidopexy and Ferguson hemorrhoidectomy: perioperative and 1-year results. Dis Colon Rectum, 2004;47:1824–36.
Peng, B.C., D.G. Jayne, and Y.H. Ho. Randomized trial of rubber band ligation versus stapled hemorrhoidectomy for prolapsed piles. Dis Colon Rectum, 2003;46:291–7; discussion 296–7.
Lan, P., et al. The safety and efficacy of stapled hemorrhoidectomy in the treatment of hemorrhoids: a systematic review and meta-analysis of ten randomized control trials. Int J Colorectal Dis, 2005.
Nisar, P.J., et al. Stapled hemorrhoidopexy compared with conventional hemorrhoidectomy: systematic review of randomized, controlled trials. Dis Colon Rectum, 2004;47:1837–45.
Oughriss, M., R. Yver, and J.L. Faucheron, Complications of stapled hemorrhoidectomy: a French multicentric study. Gastroenterol Clin Biol, 2005;29:429–33.
Nivatvongs, S. Pilonidal disease. In: Principles and Practice of Surgery for the Colon, Rectum, and Anus, P.H. Gordon and S. Nivatvongs, eds. St. Louis: Quality Medical; 1999:287–302.
Bascom, J. Pilonidal disease: origin from follicles of hairs and results of follicle removal as treatment. Surgery, 1980;87:567–72.
Marks, J., et al. Pilonidal sinus excision-healing by open granulation. Br J Surg, 1985;72:637–40.
Jensen, S.L., and H. Harling. Prognosis after simple incision and drainage for a first-episode acute pilonidal abscess. Br J Surg, 1988;75:60–1.
Armstrong, J.H., and P.J. Barcia. Pilonidal sinus disease. The conservative approach. Arch Surg, 1994;129:914–7; discussion 917–9.
Allen-Mersh, T.G. Pilonidal sinus: finding the right track for treatment. Br J Surg, 1990;77:123–32.
Akinci, O.F. Limited separate ellyptical excision for complicated pilonidal disease. Colorectal Dis, 2005;7:424–5.
Akinci, O.F., A. Coskun, and A. Uzunkoy. Simple and effective surgical treatment of pilonidal sinus: asymmetric excision and primary closure using suction drain and subcuticular skin closure. Dis Colon Rectum, 2000;43:701–6; discussion 706–7.
Akca, T., et al. Randomized clinical trial comparing primary closure with the Limberg flap in the treatment of primary sacrococcygeal pilonidal disease. Br J Surg, 2005;92:1081–4.
Nelson, R., et al. Community-based prevalence of anal incontinence. JAMA, 1995;274:559–61.
Ryhammer, A.M., S. Laurberg, and A.P. Hermann. Long-term effect of vaginal deliveries on anorectal function in normal per-imenopausal women. Dis Colon Rectum, 1996;39:852–9.
Gordon, P.H. Anal incontinence. In: Principles and Practice of Surgery for the Colon, Rectum, and Anus, S. Nivatvongs and P.H. Gordon, eds. St. Louis: Quality Medical; 1999:365–400.
Hill, J., A. Mumtaz, and E.S. Kiff. Pudendal neuropathy in patients with idiopathic faecal incontinence progresses with time. Br J Surg, 1994;81:1494–5.
Henry, M.M. Descending perineum syndrome. In: Coloproctol-ogy and the Pelvic Floor: Pathophysiology and Management, M.M. Henry and M. Swash, eds. London: Butterworths; 1985: 299–303.
Jameson, J.S., et al. Effect of age, sex and parity on anorectal function. Br J Surg, 1994;81:1689–92.
Sultan, A.H., et al. Endosonography of the anal sphincters: normal anatomy and comparison with manometry. Clin Radiol, 1994;49:368–74.
Falk, P.M., et al. Transanal ultrasound and manometry in the evaluation of fecal incontinence. Dis Colon Rectum, 1994;37:468–72.
Sangwan, Y.P., and J.A. Coller. Fecal incontinence. Surg Clin North Am, 1994;74:1377–98.
Cheong, D.M., et al. Electrodiagnostic evaluation of fecal incontinence. Muscle Nerve, 1995;18:612–9.
Shelton, A.A., and M.L. Welton. The pelvic floor in health and disease. West J Med, 1997;167:90–8.
Wong, W.D., et al. The safety and efficacy of the artificial bowel sphincter for fecal incontinence: results from a multicenter cohort study. Dis Colon Rectum, 2002;45:1139–53.
Tjandra, J.J., et al. Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective. Dis Colon Rectum, 2004;47:2138–46.
Ko, C.Y., et al. Biofeedback is effective therapy for fecal incontinence and constipation. Arch Surg, 1997;132:829–33; discussion 833–4.
Duthie, G.S., and D.C. Bartolo. Abdominal rectopexy for rectal prolapse: a comparison of techniques. Br J Surg, 1992;79:107–13.
Sayfan, J., et al. Sutured posterior abdominal rectopexy with sigmoidectomy compared with Marlex rectopexy for rectal prolapse. Br J Surg, 1990;77:143–5.
Athanasiadis, S., et al. The risk of infection of three synthetic materials used in rectopexy with or without colonic resection for rectal prolapse. Int J Colorectal Dis, 1996;11:42–4.
Huber, F.T., H. Stein, and J.R. Siewert. Functional results after treatment of rectal prolapse with rectopexy and sigmoid resection. World J Surg, 1995;19:138–43; discussion 143.
Luukkonen, P., U. Mikkonen, and H. Jarvinen. Abdominal rectopexy with sigmoidectomy versus rectopexy alone for rectal prolapse: a prospective, randomized study. Int J Colorectal Dis, 1992;7:219–22.
McKee, R.F., et al. A prospective randomized study of abdominal rectopexy with and without sigmoidectomy in rectal prolapse. Surg Gynecol Obstet, 1992;174:145–8.
Watts, J.D., et al. The management of procidentia. 30 years’ experience. Dis Colon Rectum, 1985;28:96–102.
Husa, A., P. Sainio, and K. von Smitten. Abdominal rectopexy and sigmoid resection (Frykman-Goldberg operation) for rectal prolapse. Acta Chir Scand, 1988;154:221–4.
Lehur, P.A., et al. [Sacral rectopexy-sigmoidectomy in the treatment of rectal prolapse syndrome. Anatomical and functional results]. Gastroenterol Clin Biol, 1996;20:172–7.
Augenbraun, M.H., and W.M. McCormack. Sexually transmitted diseases in HIV-infected persons. Infect Dis Clin North Am, 1994;8:439–48.
Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep, 2002;51(RR-6):1–78.
Workowski, K.A., and S.M. Berman. CDC sexually transmitted diseases treatment guidelines. Clin Infect Dis, 2002;35(suppl 2):S135–7.
Weinstock, H., D. Dean, and G. Bolan. Chlamydia trachomatis infections. Infect Dis Clin North Am, 1994;8:797–819.
Sturm, P.D., et al. Molecular diagnosis of lymphogranuloma venereum in patients with genital ulcer disease. J Clin Microbiol, 2005;43:2973–5.
Lewis, D.A. Chancroid: clinical manifestations, diagnosis, and management. Sex Transm Infect, 2003;79:68–71.
Goldstone, S.E., A.Z. Kawalek, and J.W. Huyett. Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum, 2005;48:1042–54.
Wiltz, O.H., M. Torregrosa, and O. Wiltz. Autogenous vaccine: the best therapy for perianal condyloma acuminata? Dis Colon Rectum, 1995;38:838–41.
Fleshner, P.R., and M.I. Freilich. Adjuvant interferon for anal condyloma. A prospective, randomized trial. Dis Colon Rectum, 1994;37:1255–9.
Bjorck, M., L. Athlin, and B. Lundskog. Giant condyloma acuminatum (Buschke-Loewenstein tumour) of the anorectum with malignant transformation. Eur J Surg, 1995;161:691–4.
Jass, J.R., and L.H. Sobin. Histologic Typing of Intestinal Tumors. New York: Springer-Verlag; 1989.
Welton, M.L., F.E. Sharkey, and M.S. Kahlenberg. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am, 2004;13:263–75.
Berry, J.M., J.M. Palefsky, and M.L. Welton. Anal cancer and its precursors in HIV-positive patients: perspectives and management. Surg Oncol Clin N Am, 2004;13:355–73.
Fuchshuber, P.R., et al. Anal canal and perianal epidermoid cancers. J Am Coll Surg, 1997;185:494–505.
Touboul, E., et al. Epidermoid carcinoma of the anal margin: 17 cases treated with curative-intent radiation therapy. Radiother Oncol, 1995;34:195–202.
Paterson, C.A., T.M. Young-Fadok, and R.R. Dozois. Basal cell carcinoma of the perianal region: 20-year experience. Dis Colon Rectum, 1999;42:1200–2.
Beck, D.E. Paget’s disease and Bowen’s disease of the anus. Semin Colon Rectal Surg, 1995;6:143–149.
Marchesa, P., et al. Perianal Bowen’s disease: a clinicopathologic study of 47 patients. Dis Colon Rectum, 1997;40:1286–93.
McCarter, M.D., et al. Long-term outcome of perianal Paget’s disease. Dis Colon Rectum, 2003;46:612–6.
Gordon, P.H. Current status—perianal and anal canal neoplasms. Dis Colon Rectum, 1990;33:799–808.
Boman, B.M., et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer, 1984;54:114–25.
Papillon, J., and J.F. Montbarbon. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum, 1987;30:324–33.
Cummings, B.J., et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys, 1991;21:1115–25.
Allal, A., et al. Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys, 1993;27:59–66.
Bartelink, H., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol, 1997;15:2040–9.
Flam, M., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol, 1996;14:2527–39.
Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet, 1996;348:1049–54.
Nigro, N.D. Multidisciplinary management of cancer of the anus. World J Surg, 1987;11:446–51.
Nguyen, W.D., K.M. Mitchell, and D.E. Beck. Risk factors associated with requiring a stoma for the management of anal cancer. Dis Colon Rectum, 2004;47:843–6.
Ghouti, L., et al. Salvage abdominoperineal resection after failure of conservative treatment in anal epidermoid cancer. Dis Colon Rectum, 2005;48:16–22.
Abulafi, A.M., et al. Delorme’s operation for rectal prolapse. Ann R Coll Surg Engl, 1990;72:382–5.
Graf, W., et al. Delorme’s operation for rectal prolapse in elderly or unfit patients. Eur J Surg, 1992;158:555–7.
White, S., and R.W. Stitz, Rectal prolapse: Delorme or Ripstein repair. Aust N Z J Surg, 1992;62:193–5.
Oliver, G.C., et al. Delorme’s procedure for complete rectal prolapse in severely debilitated patients. An analysis of 41 cases. Dis Colon Rectum, 1994;37:461–7.
Senapati, A., et al. Results of Delorme’s procedure for rectal prolapse. Dis Colon Rectum, 1994;37:456–60.
Tobin, S.A., and I.H. Scott. Delorme operation for rectal prolapse. Br J Surg, 1994;81:1681–4.
Lechaux, J.P., D. Lechaux, and M. Perez. Results of Delorme’s procedure for rectal prolapse. Advantages of a modified technique. Dis Colon Rectum, 1995;38:301–7.
Plusa, S.M., et al. Physiological changes after Delorme’s procedure for full-thickness rectal prolapse. Br J Surg, 1995;82:1475–8.
Altemeier, W.A., et al. Nineteen years’ experience with the one-stage perineal repair of rectal prolapse. Ann Surg, 1971;173:993–1006.
Finlay, I.G., and M. Aitchison. Perineal excision of the rectum for prolapse in the elderly. Br J Surg, 1991;78:687–9.
Williams, J.G., et al. Treatment of rectal prolapse in the elderly by perineal rectosigmoidectomy. Dis Colon Rectum, 1992;35:830–4.
Johansen, O.B., et al. Perineal rectosigmoidectomy in the elderly. Dis Colon Rectum, 1993;36:767–72.
Michelassi, F., and J.W. Milsom, eds. Operative Strategies in Inflammatory Bowel Disease. New York: Springer-Verlag; 1999.
Gordon, P.H., and S. Nivatvongs, eds. Principles and Practice of Surgery for the Colon, Rectum, and Anus. St. Louis: Quality Medical; 1999.
Painter, N.S. Diverticular disease of the colon. Gastroenterol Clin North Am, 1975;4:3–21.
Allen, J.I. Molecular biology of colorectal cancer: a clinician’s view. Perspect Colon Rectal Surg, 1995;8:181–202.
Bailey, H.R. and M.J. Synder, eds. Ambulatory Anorectal Surgery. New York: Springer-Verlag, 2000.
Corman, M.L., ed. Colon and Rectal Surgery. 4th ed. New York: Lippincott Williams & Wilkins; 1998.
Vasilevsky, C.A. Fistula-in-ano and abscess. In: Fundamentals of Anorectal Surgery, D.E. Beck and S.D. Wexner, eds. New York: McGraw-Hill; 1992.
Parks, A.G., P.H. Gordon, and J.D. Hardcastle. A classification of fistula-in-ano, Br J Surg, 1976;63:1–12.
Ustynoski, K. Horseshoe abscess fistula. Seton treatment. Dis Colon Rectum, 1990;33:602–605.
Reznick, R.K., and H.R. Bailey. Closure of internal opening for treatment of complex fistula-in-ano. Dis Colon Rectum 1988;31:116–118.
Marti M-C, and J.-C. Givel, eds. Surgical Management of Anorectal and Colonic Diseases. 2nd Ed. Heidelberg: Springer-Verlag; 1999.
Shelton, A.A., and M.L. Welton. The pelvic floor in health and disease. W J Med, 1997;167:90–8.
Berman, J.R. Delarme’s transrectal incision for interanal rectal prolapse. Dis Colon Rectum 1990;33:573.
Nivatvongs, S. The colon, rectum, and anal canal. In: Basic Surgical Practice, E.C. James and R.J. Corry, and J.F. Perry, Jr., eds. Philadelphia: Hanley and Belfus; 1987:325.
Ogorek, C.P., and Fisher, R.S. Differentiation between Crohn’s disease and ulcerative colitis. Med Clin North Am, 1994;78;1249–58.
Truelove, S.C. Medical management of ulcerative colitis and indications for colectomy. World J Surg, 1988;12:142–7.
Schroeder, K.W., W.J. Tremaine, and D.M. Ilstrup. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med, 1987;317:1625–9.
Winawer, S.J., Fletcher, H., Miller, L., et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 1997;112:594–642.
Mayeaux, E.J., et al. Noncervical human papillomavirus genital infections. Am Fam Physician, 1995;52:1137–46.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Welton, M.L., Shelton, A.A., Chang, G.J., Varma, M.G. (2008). Colon, Rectum, and Anus. In: Norton, J.A., et al. Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68113-9_52
Download citation
DOI: https://doi.org/10.1007/978-0-387-68113-9_52
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-30800-5
Online ISBN: 978-0-387-68113-9
eBook Packages: MedicineMedicine (R0)